Cargando…
Association between fetal growth restriction and polymorphisms at sites -1 and +3 of pituitary growth hormone: a case-control study
BACKGROUND: Fetal growth restriction is associated with significantly increased risks of neonatal death and morbidity and with susceptibility to hypertension, cardiovascular disease and NIDDM later in life. Human birth weight has a substantial genetic component, with at least a quarter of the variat...
Autores principales: | Adkins, Ronald M, Campese, Caroline, Vaidya, Rehana, Boyd, Theonia K |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC548522/ https://www.ncbi.nlm.nih.gov/pubmed/15691369 http://dx.doi.org/10.1186/1471-2393-5-2 |
Ejemplares similares
-
Growth without growth hormone in combined pituitary hormone deficiency caused by pituitary stalk interruption syndrome
por: Lee, Sang Soo, et al.
Publicado: (2017) -
Placental pathology in early-onset fetal growth restriction: insights into fetal growth restriction mechanisms
por: Bujorescu, Daniela-Loredana, et al.
Publicado: (2023) -
Comparison between Protocols for Management of Fetal Growth Restriction
por: Leal, Caio Ribeiro Vieira, et al.
Publicado: (2023) -
Growth assessment in diagnosis of Fetal Growth Restriction. Review
por: Albu, AR, et al.
Publicado: (2014) -
Diagnosis and Management of Fetal Growth Restriction
por: Bamfo, Jacqueline E. A. K., et al.
Publicado: (2011)